Corcept Therapeutics Incorporated (0I3Q.L) LSE

68.80

-0.68(-0.98%)

Updated at September 05 06:58PM

Currency In USD

Valuation

Market Cap5.2B
Enterprise Value5.08B
P/E Ratio54.49
PEG Ratio-69.21
Price/Sales Ratio10.21
Price/Book Ratio11.36
Enterprise/Revenue10.07
Enterprise/EBITDA69.46

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.19
Operating Margin0.14

Management Effectiveness

Return On Assets0.17
Return On Equity0.2

Income Statement

Revenue675.04M
Revenue/Share6.88
Gross Profit664.16M
EBITDA136.95M
Net Income139.73M
Diluted EPS1.23

Balance Sheet

Total Cash342.23M
Total Cash/Share3.29
Total Debt6.61M
Total Debt/Equity0.01
Current Ratio3.06
Book Value Per Share6.11

Price History

52-Week Change98.39
52-Week High69.63
52-Week Low20.76
Moving Average 50 Days23.44
Moving Average 200 Days26

Statistics

Average Volume2,318
Shares Outstanding105.37M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A